Characterization and Targeting of p53 Ubiquitination in Neuroblastoma.
|
Baylor College of Medicine / Eveline Barbieri, MD, PhD |
Young Investigator Grants |
2008 |
Texas |
Identification and Characterization of Pathways Dysregulated by MMSET E1099K Mutation in Relapsed Pediatric Acute Lymphoblastic Leukemia and Their Role in Drug Resistance |
New York University School of Medicine / Joanna Pierro, DO |
Young Investigator Grants |
2017 |
New York |
Divergent Core Transcriptional Regulatory Circuitries to Highlight Context-Specific Vulnerabilities in AML |
Dana-Farber Cancer Institute / Maxim Pimkin, MD/PhD |
Young Investigator Grants |
2018 |
Massachusetts |
Hedgehog & IGF Signaling through IRSI in Brain Development and Medulloblastoma
|
Memorial Sloan-Kettering Cancer Center / Anna Marie Kenney, PhD |
Young Investigator Grants |
2006 |
New York |
The Cebpa Downstream Enhancer as a Key Target of Transformation to Acute Myeloid Leukemia |
The Johns Hopkins University School of Medicine / Stacy Cooper, MD |
Young Investigator Grants |
2015 |
Maryland |
Hospital Volume and Induction Mortality in Children, Adolescents, and Young Adults with Acute Leukemia |
Children’s Hospital of Philadelphia / Jennifer Wilkes, MD |
Young Investigator Grants |
2014 |
Pennsylvania |
Targeted Hyperactivation of PI3K/AKT in B-cell malignancies |
Dana-Farber Cancer Institute / Vishal Khairnar, PhD |
Young Investigator Grants |
2019 |
Massachusetts |
Identification of Alveolar Rhabdomyosarcoma "Achilles' Heel" |
National Cancer Institute / Fernanda Arnaldez |
Young Investigator Grants |
2011 |
Maryland |
Identifying Disease Mechanisms and Therapeutic Opportunities in Pediatric Low-grade Gliomas Driven by MYB-QKI Fusions |
Dana-Farber Cancer Institute / Cecile Rouleau, PhD |
Young Investigator Grants |
2017 |
Massachusetts |
Novel Antibodies to the C2-set Domain of CD33 for Acute Myeloid Leukemia Immunotherapy |
Fred Hutchinson Cancer Research Center / Colin Godwin, MD |
Young Investigator Grants |
2018 |
Washington |